Stock Market Watch

Eight NASDAQ Stocks under Three Bucks to Watch on Friday

by ·









Seven Arts Pictures plc (NASDAQ:SAPX) traded as high as $.0958 during Thursday’s trading session and last traded at the high for a gain of 71.07% from Wednesday’s close… SAPX shares have traded as high as $5.75 over the past 52 weeks, which is 98.33% off that high at last traded stock price. Get my next ALERT 100% FREE

Seven Arts Pictures PLC is engaged in the development, financing, production and licensing of theatrical motion pictures for exhibition in domestic and international theatrical markets, and for worldwide release in other forms of media.

Vermillion, Inc. (NASDAQ:VRML) traded as high as $2.80 during Thursday’s trading session and last traded at $2.72 for a gain of 47.83% from Wednesday’s close… VRML shares have traded as high as $5.69 over the past 52 weeks, which is 52.2% off that high at last traded stock price.


Vermillion, Inc. is engaged in the discovery, development and commercialization of diagnostic tests that help physicians diagnose, treat and improve outcomes for patients.

Arca Biopharma Inc (NASDAQ:ABIO) traded as high as $.68 during Thursday’s trading session and last traded at $.60 for a gain of 38.57% from Wednesday’s close… ABIO shares have traded as high as $2.45 over the past 52 weeks, which is 75.51% off that high at last traded stock price.

ARCA biopharma, Inc., is a biopharmaceutical company. The Company’s principal focus is developing genetically-targeted therapies for heart failure and other cardiovascular diseases.

Complete Genomics, Inc. (NASDAQ:GNOM) traded as high as $2.79 during Thursday’s trading session and last traded at $2.40 for a gain of 30.43% from Wednesday’s close… GNOM shares have traded as high as $18.55 over the past 52 weeks, which is 87.06% off that high at last traded stock price. Get my next ALERT 100% FREE

Complete Genomics Inc is a life sciences company that has developed and commercialized an innovative DNA sequencing platform that provides preferred solution for complete human genome sequencing and analysis.

BSD Medical Corporation (NASDAQ:BSDM) traded as high as $2 during Thursday’s trading session and last traded at the high for a gain of 20.41% from Wednesday’s close… BSDM shares have traded as high as $4.50 over the past 52 weeks, which is 55.56% off that high at last traded stock price.

BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and delivers using focused radiofrequency (RF) and microwave energy. BSD business focuses to commercialize the products for the treatment of cancer.

Swisher Hygiene Inc (NASDAQ:SWSH) traded as high as $2.24 during Thursday’s trading session and last traded at $2.08 for a gain of 20.23% from Wednesday’s close… SWSH shares have traded as high as $6.77 over the past 52 weeks, which is 69.28% off that high at last traded stock price.

Swisher Hygiene is a NASDAQ and TSX listed company that provides essential hygiene and sanitation solutions to customers throughout much of North America and internationally through its global network of company-owned operations, franchises and master licensees operating in countries across Europe and Asia.

MediciNova, Inc. (NASDAQ:MNOV) traded as high as $1.66 during Thursday’s trading session and last traded at $1.63 for a loss of 40.73% from Wednesday’s close… MNOV shares have traded as high as $3.95 over the past 52 weeks, which is 58.73% off that high at last traded stock price. Get my next ALERT 100% FREE

Medicinova, Inc. is a biopharmaceutical company, which is focused on acquiring and developing novel, small molecule therapeutics for the treatment of diseases with unmet medical need with a specific focus on the U.S. market.

Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) traded as high as $.80 during Thursday’s trading session and last traded at $.565 for a loss of 35.06% from Wednesday’s close… CPRX shares have traded as high as $2.25 over the past 52 weeks, which is 74.89% off that high at last traded stock price.

Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction and diseases of the central nervous system.








More Posts by this author

Post Written By: Oliver Crowne

Oliver Crowne is the main editor for http://www.StockPreacher.com


Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...